By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics has filed for the registration of up to $7 million in additional shares in connection to a stock option being offered to employees.

In a document filed with the US Securities and Exchange Commission on Monday, the Mountain View, Calif.-based sequencing services firm registered about 1.6 million shares of its common stock at a proposed maximum offering price of $4.53 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.